Company News »

Transgenomic to Present at BTIG Emerging Technologies in Healthcare Diagnostics Conference

Business Wire
Share on StockTwits
Published on

Transgenomic, Inc. (NASDAQ:TBIO) , a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that senior management will participate in the BTIG Emerging Technologies in Healthcare Diagnostics conference. Transgenomic’s Executive Vice President and Chief Financial Officer Mark Colonnese will discuss Personalized Medicine in the CLIA Lab on Monday, September 29, 2014 at 4:10 pm ET.

The BTIG Emerging Technologies in Healthcare Diagnostics conference is being held at the Benjamin Hotel in New York City September 29-30, 2014. For more information, contact: resources@btig.com.

About Transgenomic
Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD-PCRTM and its unique genetic tests provided through its Patient Testing business. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies and sells equipment, reagents and other consumables for applications in molecular testing and cytogenetics. Transgenomic’s diagnostic technologies are designed to improve medical diagnoses and patient outcomes.

Share on StockTwits

What others are reading on Finances

Sorry. No data so far.


Iron FX 1.11156/1.11128 2.8
XM Markets 1.09948/1.09928 2
FxPro 1.10184/1.10171 1.3
FXCM 1.13943/1.13912 3.1